Studies | Population | PD | Results |
---|---|---|---|
Aydin et al. (2017) [27] | PsO | NPD: 84.6% | Presence of nail bed with PD signal was similar among patients with PsO and healthy controls. |
Controls | NPD: 81.6% | ||
Paramalingam et al. (2017) [29] | PsA | NPD: 96.0% | Patients with PsA presented with a slightly higher percentage of nails with PD signal than patients with OA. |
OA | NPD: 95.0% | ||
Acquitter et al. (2016) [30] | Patients with PsO with nail disease | NPD: 44.5% | NPD was higher in patients with PsO with nail disease; however, differences among groups were not significant. |
Patients with scalp PsO and/or inverse PsO | NPD: 39.0% | ||
Mendonça et al. (2014) [34] | PsA | NPD mean (SD): 0.88 (0.31) | NPD was slightly lower in patients with PsA than controls. |
Controls | NPD mean (SD): 1.0 (0.00) | ||
Sandobal et al. (2014) [35] | PsO | Increase PD signal in nail beds: 20.5% | Patients with psoriatic arthropathy showed increased PD signal in nail bed (p = 0.0001). |
PsA | Increase PD signal in nail beds: 23.4% | ||
RA | Increase PD signal in nail beds: 2.2% | ||
Controls | Increase PD signal in nail beds: 19.6% | ||
Haddad et al. (2012) [39] | PsO | Nail bed vascularity: 14% | Comparing the three groups, patients with PsO and PsA presented with statistically significantly lower values of nail bed vascularity than controls (p < 0.001). Comparing patients with PsO and PsA, patients with PsO presented with lower nail bed vascularity than patients with PsA; however, no statistically significant differences were observed (p = 0.44). |
PsA | Nail bed vascularity: 18% | ||
Controls | Nail bed vascularity: 20% |